-
EP0777484
European procedure
Extract from the Register of European Patents
EP About this file: EP0777484
| EP0777484 - INTRAVENOUS ALENDRONATE FORMULATIONS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 04.02.2005 Database last updated on 16.07.2024 | Most recent event Tooltip | 16.03.2007 | Lapse of the patent in a contracting state New state(s): LU | published on 18.04.2007 [2007/16] | Applicant(s) | For all designated states Merck & Co., Inc. 126, East Lincoln Avenue P.O. Box 2000 Rahway New Jersey 07065-0900 / US | [N/P] |
| Former [1997/24] | For all designated states Merck & Co., Inc. 126, East Lincoln Avenue P.O. Box 2000 Rahway New Jersey 07065-0900 / US | Inventor(s) | 01 /
BRENNER, Gerald S. 126 East Lincoln Avenue Rahway, NJ 07065 / US | 02 /
GHANNAM, Musa M. 126 East Lincoln Avenue Rahway, NJ 07065 / US | [1997/24] | Representative(s) | Horgan, James Michael Frederic, et al Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road, Harlow Essex CM20 2QR / GB | [N/P] |
| Former [2004/27] | Horgan, James Michael Frederic, et al Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road Harlow, Essex CM20 2QR / GB | ||
| Former [1997/24] | Hiscock, Ian James, et al European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road Harlow, Essex CM20 2QR / GB | Application number, filing date | 95929625.2 | 21.08.1995 | [1997/24] | WO1995US10583 | Priority number, date | US19940296192 | 24.08.1994 Original published format: US 296192 | [1997/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9605842 | Date: | 29.02.1996 | Language: | EN | [1996/10] | Type: | A1 Application with search report | No.: | EP0777484 | Date: | 11.06.1997 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.02.1996 takes the place of the publication of the European patent application. | [1997/24] | Type: | B1 Patent specification | No.: | EP0777484 | Date: | 31.03.2004 | Language: | EN | [2004/14] | Search report(s) | International search report - published on: | US | 29.02.1996 | (Supplementary) European search report - dispatched on: | EP | 19.06.1998 | Classification | IPC: | A61K31/685, A61K47/12 | [1998/29] | CPC: |
A61K31/663 (EP,US);
A61K47/02 (EP,US);
A61K47/12 (EP,US);
A61K9/0019 (EP,US);
A61P19/08 (EP);
A61P19/10 (EP);
|
| Former IPC [1997/24] | A61K31/685 | Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, NL, PT, SE [1997/24] | Title | German: | INTRAVENÖSE ALENDRONATFORMULIERUNGEN | [1997/24] | English: | INTRAVENOUS ALENDRONATE FORMULATIONS | [1997/24] | French: | FORMULATIONS INTRAVEINEUSES D'ALENDRONATE | [1997/24] | Entry into regional phase | 24.03.1997 | National basic fee paid | 24.03.1997 | Search fee paid | 24.03.1997 | Designation fee(s) paid | 24.03.1997 | Examination fee paid | Examination procedure | 22.03.1996 | Request for preliminary examination filed International Preliminary Examining Authority: US | 24.03.1997 | Examination requested [1997/24] | 11.08.1998 | Amendment by applicant (claims and/or description) | 01.12.1999 | Despatch of a communication from the examining division (Time limit: M04) | 31.03.2000 | Reply to a communication from the examining division | 24.01.2001 | Despatch of a communication from the examining division (Time limit: M06) | 03.08.2001 | Reply to a communication from the examining division | 19.07.2002 | Despatch of a communication from the examining division (Time limit: M06) | 24.01.2003 | Reply to a communication from the examining division | 14.07.2003 | Communication of intention to grant the patent | 26.01.2004 | Fee for grant paid | 26.01.2004 | Fee for publishing/printing paid | Opposition(s) | 04.01.2005 | No opposition filed within time limit [2005/12] | Fees paid | Renewal fee | 01.09.1997 | Renewal fee patent year 03 | 31.08.1998 | Renewal fee patent year 04 | 31.08.1999 | Renewal fee patent year 05 | 31.08.2000 | Renewal fee patent year 06 | 31.08.2001 | Renewal fee patent year 07 | 02.09.2002 | Renewal fee patent year 08 | 06.08.2003 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CH | 31.03.2004 | LI | 31.03.2004 | DK | 30.06.2004 | GR | 30.06.2004 | SE | 30.06.2004 | LU | 21.08.2004 | IE | 23.08.2004 | [2007/16] |
| Former [2005/46] | CH | 31.03.2004 | |
| LI | 31.03.2004 | ||
| DK | 30.06.2004 | ||
| GR | 30.06.2004 | ||
| SE | 30.06.2004 | ||
| IE | 23.08.2004 | ||
| Former [2005/18] | CH | 31.03.2004 | |
| LI | 31.03.2004 | ||
| DK | 30.06.2004 | ||
| GR | 30.06.2004 | ||
| SE | 30.06.2004 | ||
| Former [2004/51] | CH | 31.03.2004 | |
| LI | 31.03.2004 | ||
| GR | 30.06.2004 | ||
| SE | 30.06.2004 | ||
| Former [2004/41] | GR | 30.06.2004 | |
| SE | 30.06.2004 | ||
| Former [2004/40] | SE | 30.06.2004 | Documents cited: | Search | [Y]US5270365 (GERTZ BARRY J [US], et al) [Y] 1-10 * column 5, paragraph 3 ** column 10, line 34 - line 68 *; | [Y]WO9414455 (MERCK & CO INC [US], et al) [Y] 1-10 * page 7, paragraph 2; claim 2 * * page 8, paragraph 4 * | International search | [Y] - JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, No. 8, August 1993, NUSSBAUM et al., "Dose-Response Study of Alendronate Sodium for the Treatment of Cancer-Associated Hypercalcemia", pages 1618-1623. | [Y] - REMINGTON'S PHARMACEUTICAL SCIENCES, 18th Ed. (1990), pages 1549-1550. | [Y] - CANCER SUPPLEMENT, Volume 72, No. 11, issued 1 December 1993, AVERBUCH et al., "New Bisphosphonates in the Treatment of Bone Metastases", pages 3443-3452. |